Your Global Leader in Stem Cell Market Research
After being asked repeatedly about this information, we’ve decided to share with you key insights from our recent “Survey of Stem Cell Researchers.”
Previously, we shared with you the Top 5 Providers of Stem Cell Products. Congrats to five companies who made the list.
Today, we’re going to be sharing with you the three most influential factors that cause stem cell researchers to purchase from you over the competition. [Read more…]
The landscape for induced pluripotent stem cell (iPSC or iPS cell) patents has changed substantially over the past 10 years, evolving to be geographically clustered in four specific regions.
As background, groundbreaking experimentation led to the discovery of iPSCs in 2006, which are adult cells that are transformed into embryonic-like stem cells through the manipulation of gene expression or other related methods. In 2007, follow-up experiments proved human adult cells could be transformed into iPSC cells.
Since the discovery of iPSCs, a large and thriving research product market has grown into existence, largely because the cells are completely non-controversial and can be generated directly from adult cells.
Today, the number of iPSC products sold worldwide is increasing with double-digit growth, and 22% of all stem cell researchers self-report having used iPSCs within a research project. It is clear that iPSCs represent a lucrative product market, but commercializing the cell type involves careful and due diligence, because the cells are still a relatively new discovery.
Because the iPSC industry is a rapidly-evolving area, major research findings and technical discoveries are frequently announced . Therefore, to launch iPSC products and technologies, one of the key areas that company management and investors must consider is the patent landscape for the cell type. [Read more…]
As 2015 comes to an end and 2016 approaches, our team of stem cell analysts has been discussing how the new year will impact us, our partners, and our clients. As President/CEO of the first and only company specializing in stem cell markets, I spend a lot of time thinking about this topic. After substantial reflection on trends that gained momentum in 2015, I can can state with confidence that I believe the following trends will be major market research forces in 2016. [Read more…]
Hey, we’ve posted new content about stem cells and cord blood that I’m excited to share with you. Let me know what you think.
Click here to view all recently released blog posts or here to view BioInformant’s global strategic reports for the stem cell and cord blood industry. Be great!
The mesenchymal stem cell (MSC) industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.
Therefore, we are excited to share with you the following summary of major mesenchymal stem cell (MSC) industry events for October 2015.
